Horn Margaret A sold $15.0M of RVMD
Horn Margaret A (Chief Operating Officer) sold 93,575 shares of Revolution Medicines, Inc. (RVMD) at an average of $160.00 ($156.12–$160.17, $14.97M total) across 3 trades over 2025-06-16 to 2026-06-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a concrete, time-stamped insider selling event (~$14.97M) that can influence short-term sentiment, though 10b5-1 typically limits the signal of new negative information.
Market read
Traders may monitor for follow-on insider activity or correlate with upcoming company catalysts, but the filing alone is unlikely to drive a major repricing.
What to watch
The trades span multiple dates; the market may already have priced any earlier sale activity, leaving only the incremental effect of the latest filing.
Background
This is an SEC Form 4 insider transaction filing for Revolution Medicines, Inc., reporting officer (COO) share sales executed in open-market trades under a Rule 10b5-1 plan.
Ticker impact
Revolution Medicines COO Margaret A Horn sold ~$15.0M of RVMD shares in open-market transactions under a 10b5-1 plan, per SEC Form 4.
Likely limited immediate price impact; any reaction should be modest unless accompanied by other company-specific catalysts.
The filing discloses a large dollar-value sale by an officer, yet it is explicitly under a pre-arranged 10b5-1 plan, which typically dampens inference about new negative information.
Market effects
No direct sector read-through; this is a single-company insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect routine liquidity/compensation mechanics rather than a change in fundamentals.
Key entities
- issuerRevolution Medicines, Inc.
Subject of the Form 4 insider transaction; COO sold 93,575 shares for ~$14.97M under a 10b5-1 plan.
- insiderHorn Margaret A
COO who executed the open-market sales; holdings after transaction reported as 154,647 shares.
